Attached files
| file | filename |
|---|---|
| 10-Q/A - LIBERATOR MEDICAL HOLDINGS, INC. | v218337_10qa.htm |
| EX-31.2 - LIBERATOR MEDICAL HOLDINGS, INC. | v218337_ex31-2.htm |
| EX-32.1 - LIBERATOR MEDICAL HOLDINGS, INC. | v218337_ex32-1.htm |
| EX-31.1 - LIBERATOR MEDICAL HOLDINGS, INC. | v218337_ex31-1.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Robert J. Davis, the Chief Financial Officer of Liberator Medical Holdings, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. This Quarterly Report on Form 10-Q/A of the Company for the quarter ended March 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
2. The information contained in this Form 10-Q/A fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: April 13, 2011
|
/s/ Robert J. Davis
|
|
|
Robert J. Davis, Chief Financial Officer
|